CorneaGen
Latest round
- Series B
Last raised
- Oct 2019
Total raised
- $47M
Investors
- 4
About CorneaGen
CorneaGen Inc.Founded in 2016 and headquartered in Seattle, US, CorneaGen Inc. focuses on advancing corneal tissue solutions.00 mn.CorneaGen Inc. specializes in delivering innovative solutions tailored for eye care, particularly focusing on corneal transplantation technologies. Their core offerings include a range of preserved corneal tissues that meet specific patient needs, enhancing the functionality of eye surgeries.The company's revenue model is primarily based on B2B sales, where hospitals and clinics procure corneal tissues directly from CorneaGen Inc. This structured approach enables effective partnerships and a steady revenue stream, reflecting the value of their specialized offerings.CorneaGen Inc. is actively developing new product lines aimed at expanding its offerings in corneal transplant technologies. The company aims to launch these new solutions by 2023, targeting both domestic and international markets for further reach.00 mn will support these initiatives, including advancements in research and development, as well as expansion into key geographic regions to increase accessibility to their products.
Who invested in CorneaGen
4 investors across 2 rounds
See all investors in CorneaGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CorneaGen
Who invested in CorneaGen?
CorneaGen has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CorneaGen raised?
CorneaGen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CorneaGen last raise money?
CorneaGen's most recent round on record is a Series B, in Oct 2019.
What does CorneaGen do?
CorneaGen is a healthcare specialists company.
Where is CorneaGen headquartered?
CorneaGen is headquartered in Seattle, US.
Which VCs invest in companies like CorneaGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at CorneaGen's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like CorneaGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.